Vitamin D and lung cancer risk: A comprehensive review and meta-analysis

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 299-305

  Zhang, Liqun ^a   Wang, Sihai ^a   Che, Xiaoyu ^b   Li, Xuehui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Beijing Military Hospital PLA   (China)

Author keywords

Lung cancer; Risk; Vitamin D

Indexed keywords

VITAMIN D;

CANCER RISK; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; FEMALE; LUNG NEOPLASMS; MALE; RISK;

DIETARY SUPPLEMENTS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RISK; VITAMIN D;

EID: 84929884223     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374072     Document Type: Review

References (43)

1. Bolland MJ, Grey A, Gamble GD, Reid IR: The effect of vitamin d supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:307-320.
2. Mora JR, Iwata M, von Andrian UH: Vitamin effects on the immune system: Vitamins a and d take centre stage. Nat Rev Immunol 2008;8:685-698.
3. Chishimba L, Thickett DR, Stockley RA, Wood AM: The vitamin d axis in the lung: A key role for vitamin d-binding protein. Thorax 2010;65:456-462.
4. Moukayed M, Grant WB: Molecular link between vitamin d and cancer prevention. Nutrients 2013;5:3993-4021.
5. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M: Vitamin d effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev 2013;12:976-989.
6. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T: 1 alpha, 25-dihydroxyvitamin d(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005;26:429-440.
7. Mernitz H, Smith DE, Wood RJ, Russell RM, Wang XD: Inhibition of lung carcinogenesis by 1alpha, 25-dihydroxyvitamin d3 and 9-cis retinoic acid in the a/j mouse model: Evidence of retinoid mitigation of vitamin d toxicity. Int J Cancer 2007;120:1402-1409.
8. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ: The role of vitamin d in reducing cancer risk and progression. Nat Rev Cancer 2014;14:342-357.
9. Guzey M, Sattler C, DeLuca HF: Combinational effects of vitamin d3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines. Biochem Biophys Res Commun 1998;249:735-744.
10. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T: 22-oxa-1alpha, 25-dihydroxyvitamin d3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005;26:1044-1054.
11. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Roswall N, Larsen SC, Linneberg A: Prospective population-based study of the association between serum 25-hydroxyvitamin-d levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev 2014;23:1220-1229.
12. Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, LaCroix AZ, Zheng Y, Neuhouser ML: Estimated intake of vitamin d and its interaction with vitamin a on lung cancer risk among smokers. Int J Cancer 2014;135:2135-2145.
13. Ordonez-Mena JM, Schottker B, Haug U, Muller H, Kohrle J, Schomburg L, Holleczek B, Brenner H: Serum 25-hydroxyvitamin d and cancer risk in older adults: Results from a large german prospective cohort study. Cancer Epidemiol Biomarkers Prev 2013;22:905-916.
14. Afzal S, Bojesen SE, Nordestgaard BG: Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer. Clin Chem 2013;59:771-780.
15. Cheng TY, Neuhouser ML: Serum 25-hydroxyvitamin d, vitamin a, and lung cancer mortality in the us population: A potential nutrient-nutrient interaction. Cancer Causes Control 2012;23:1557-1565.
16. Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D: Serum 25-hydroxyvitamin d and risk of lung cancer in male smokers: A nested case-control study. PLoS One 2011;6:e20796.
17. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI: Serum 25-hydroxyvitamin d and cancer mortality in the nhanes iii study (1988-2006). Cancer Res 2010;70:8587-8597.
18. Kilkkinen A, Knekt P, Heliovaara M, Rissanen H, Marniemi J, Hakulinen T, Aromaa A: Vitamin d status and the risk of lung cancer: A cohort study in finland. Cancer Epidemiol Biomarkers Prev 2008;17:3274-3278.
19. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC: Prospective study of predictors of vitamin d status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-459.
20. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, Tugwell P: The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site, 2014
21. Cochran WG: The combination of estimates from different experiments. Biometrics 1954;10:101-129.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
23. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
24. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
25. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
26. Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML: Vitamin d intake and lung cancer risk in the women's health initiative. Am J Clin Nutr 2013;98:1002-1011.
27. Redaniel MT, Gardner MP, Martin RM, Jeffreys M: The association of vitamin d supplementation with the risk of cancer in postmenopausal women. Cancer Causes Control 2014;25:267-271.
28. Wong YY, Hyde Z, McCaul KA, Yeap BB, Golledge J, Hankey GJ, Flicker L: In older men, lower plasma 25-hydroxyvitamin d is associated with reduced incidence of prostate, but not colorectal or lung cancer. PLoS One 2014;9:e99954.
29. Takata Y, Shu XO, Yang G, Li H, Dai Q, Gao J, Cai Q, Gao YT, Zheng W: Calcium intake and lung cancer risk among female nonsmokers: A report from the shanghai women's health study. Cancer Epidemiol Biomarkers Prev 2013;22:50-57.
30. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP: Association between reduced plasma 25-hydroxy vitamin d and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:821-827.
31. Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG: Vitamin d concentration, obesity, and risk of diabetes: A mendelian randomisation study. Lancet Diabetes Endocrinol 2014;2:298-306.
32. Bolland MJ, Grey A, Gamble GD, Reid IR: Vitamin d supplementation and falls: A trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:573-580.
33. Autier P, Boniol M, Pizot C, Mullie P: Vitamin d status and ill health: A systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
34. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P: Meta-analysis of observational studies of serum 25-hydroxyvitamin d levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128:1414-1424.
35. Li M, Chen P, Li J, Chu R, Xie D, Wang H: Review: The impacts of circulating 25-hydroxyvitamin d levels on cancer patient outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:2327-2336.
36. Wang B, Jing Z, Li C, Xu S, Wang Y: Blood 25-hydroxyvitamin d levels and overall mortality in patients with colorectal cancer: A dose-response meta-analysis. Eur J Cancer 2014;50:2173-2175.
37. Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, Berruti A: Prognostic role of vitamin d status and efficacy of vitamin d supplementation in cancer patients: A systematic review. Oncologist 2011;16:1215-1227.
38. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE: Serum levels of 25-hydroxyvitamin d and survival in norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012;23:363-370.
39. Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Giovannucci E, Christiani DC: Vitamin d is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005;14:2303-2309.
40. Liu Y, Chen W, Hu ZB, Xu L, Shu YQ, Pan SY, Dai JC, Jin GF, Ma HX, Shen HB: Plasma vitamin d levels and vitamin d receptor polymorphisms are associated with survival of non-small cell lung cancer. Chin J Cancer Res 2011;23:33-37.
41. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, Asomaning K, Hollis BW, Lynch TJ, Wain JC, Giovannucci E, Christiani DC: Circulating 25-hydroxyvitamin d, vdr polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008;26:5596-5602.
42. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC: Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007;25:479-485.
43. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J, Gluud C. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev. 2014;6:CD007469.